Cart
sales@molnova.com
C-Met inhibitor D9
CAS No. 299405-67-7
C-Met inhibitor D9( —— )
Catalog No. M36033 CAS No. 299405-67-7
C-Met inhibitor D9 is a c-Met kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 426 | In Stock |
|
| 10MG | 625 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1283 | In Stock |
|
| 100MG | 1758 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3515 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameC-Met inhibitor D9
-
NoteResearch use only, not for human use.
-
Brief DescriptionC-Met inhibitor D9 is a c-Met kinase inhibitor.
-
DescriptionC-Met inhibitor D9 is a c-Met kinase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Met/HGFR
-
Recptorc-Met/HGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number299405-67-7
-
Formula Weight293.32
-
Molecular FormulaC17H15N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(NC(CCC1=CC=CC=C1)=O)=C2C=3C(NC2=O)=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PHA-665752
PHA-665752 is a potent, selective, ATP-competitive c-Met inhibitor with Ki/IC50 of 4/9 nM.
-
Terevalefim
Terevalefim (ANG-3777), an hepatocyte growth factor (HGF) mimetic, selectively activates the c-Met receptor.
-
Cabozantinib hydroch...
Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2 c-Met Kit Axl and Flt4 (IC50s: 0.035 1.3 4.6 7 and 6 nM).
